Home > > > > Report Detail

Global Infantile Spasms Therapeutics Market Size, Status and Forecast 2020-2026

Publisher Name :
Date: 22-Apr-2020
No. of pages: 95
Inquire Before Buying

An infantile spasm (IS), also known as West Syndrome, is a specific type of seizure seen in an epilepsy syndrome of infancy and childhood. West Syndrome is characterized by infantile spasms, developmental regression, and a specific pattern on electroencephalography (EEG) testing called hypsarrhythmia (chaotic brain waves). The onset of infantile spasms is usually in the first year of life, typically between 4-8 months. The seizures primarily consist of a sudden bending forward of the body with stiffening of the arms and legs; some children arch their backs as they extend their arms and legs. The condition is usually observed in 2% of childhood epilepsies and 25% of epilepsies that start in the first year of life.

The global infantile spasms therapeutics market is growing at a slow pace. This is due to the increased availability of generic drugs and less approved therapies in the market and the less awareness of the disease and the available treatment options, especially in the low- and middle-income countries.

The classification of Infantile Spasms Therapeutics includes Oral, Injection. The proportion of Injection in 2016 is about 45%, and the proportion of Oral in 2016 is about 55%.

Based on application, the nitinol medical devices market is segmented into Hospital, Clinic and others. Clinic segment accounted for larger market share in terms of sales in 2016, Clinic segmented accounted for more than 45% of the market share in 2016.

United States is the largest consumption place, with a consumption market share nearly 83% in 2016. Following United States, Europe is the second largest consumption place with the consumption market share of 12.6% in 2016.

The US market is dominated by two approved products H.P. Acthar Gel (adrenocorticotropin hormone) and Sabril (vigabatrin). Sabril was the first drug to be approved by the Food and Drug Administration (FDA) in 2009 and H.P. Acthar Gel (adrenocorticotropin hormone) was approved for infantile spasms in 2010. Both have Orphan Drug Exclusivity (ODE) in the US.

In the future, the Infantile Spasms Therapeutics will have a good future; the price fluctuation has relationship with the raw material. The technology will more mature and the industry is more dispersion.

Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Infantile Spasms Therapeutics market in 2020.

COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.

The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.

This report also analyses the impact of Coronavirus COVID-19 on the Infantile Spasms Therapeutics industry.

Based on our recent survey, we have several different scenarios about the Infantile Spasms Therapeutics YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 138.9 million in 2019. The market size of Infantile Spasms Therapeutics will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Infantile Spasms Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Infantile Spasms Therapeutics market in terms of revenue.

Players, stakeholders, and other participants in the global Infantile Spasms Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.

Regional and Country-level Analysis

The report offers an exhaustive geographical analysis of the global Infantile Spasms Therapeutics market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.

Competition Analysis

In the competitive analysis section of the report, leading as well as prominent players of the global Infantile Spasms Therapeutics market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Infantile Spasms Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Infantile Spasms Therapeutics market.

The following players are covered in this report:

- Mallinckrodt

- H. Lundbeck

- Insys Therapeutics

- Orphelia Pharma

- Valerion Therapeutics

- Catalyst Pharmaceuticals

- Anavex Life Sciences

- Retrophin

- GW Pharmaceuticals

Infantile Spasms Therapeutics Breakdown Data by Type

- Oral

- Injection

Infantile Spasms Therapeutics Breakdown Data by Application

- Hospital

- Clinic

Global Infantile Spasms Therapeutics Market Size, Status and Forecast 2020-2026

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Infantile Spasms Therapeutics Revenue
1.4 Market Analysis by Type
1.4.1 Global Infantile Spasms Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Oral
1.4.3 Injection
1.5 Market by Application
1.5.1 Global Infantile Spasms Therapeutics Market Share by Application: 2020 VS 2026
1.5.2 Hospital
1.5.3 Clinic
1.6 Coronavirus Disease 2019 (Covid-19): Infantile Spasms Therapeutics Industry Impact
1.6.1 How the Covid-19 is Affecting the Infantile Spasms Therapeutics Industry
1.6.1.1 Infantile Spasms Therapeutics Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19's Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Infantile Spasms Therapeutics Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Infantile Spasms Therapeutics Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends by Regions
2.1 Infantile Spasms Therapeutics Market Perspective (2015-2026)
2.2 Infantile Spasms Therapeutics Growth Trends by Regions
2.2.1 Infantile Spasms Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Infantile Spasms Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 Infantile Spasms Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter's Five Forces Analysis
2.3.5 Infantile Spasms Therapeutics Market Growth Strategy
2.3.6 Primary Interviews with Key Infantile Spasms Therapeutics Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Infantile Spasms Therapeutics Players by Market Size
3.1.1 Global Top Infantile Spasms Therapeutics Players by Revenue (2015-2020)
3.1.2 Global Infantile Spasms Therapeutics Revenue Market Share by Players (2015-2020)
3.1.3 Global Infantile Spasms Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Infantile Spasms Therapeutics Market Concentration Ratio
3.2.1 Global Infantile Spasms Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Infantile Spasms Therapeutics Revenue in 2019
3.3 Infantile Spasms Therapeutics Key Players Head office and Area Served
3.4 Key Players Infantile Spasms Therapeutics Product Solution and Service
3.5 Date of Enter into Infantile Spasms Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Infantile Spasms Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Infantile Spasms Therapeutics Forecasted Market Size by Type (2021-2026)
5 Infantile Spasms Therapeutics Breakdown Data by Application (2015-2026)
5.1 Global Infantile Spasms Therapeutics Market Size by Application (2015-2020)
5.2 Global Infantile Spasms Therapeutics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Infantile Spasms Therapeutics Market Size (2015-2020)
6.2 Infantile Spasms Therapeutics Key Players in North America (2019-2020)
6.3 North America Infantile Spasms Therapeutics Market Size by Type (2015-2020)
6.4 North America Infantile Spasms Therapeutics Market Size by Application (2015-2020)
7 Europe
7.1 Europe Infantile Spasms Therapeutics Market Size (2015-2020)
7.2 Infantile Spasms Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Infantile Spasms Therapeutics Market Size by Type (2015-2020)
7.4 Europe Infantile Spasms Therapeutics Market Size by Application (2015-2020)
8 China
8.1 China Infantile Spasms Therapeutics Market Size (2015-2020)
8.2 Infantile Spasms Therapeutics Key Players in China (2019-2020)
8.3 China Infantile Spasms Therapeutics Market Size by Type (2015-2020)
8.4 China Infantile Spasms Therapeutics Market Size by Application (2015-2020)
9 Japan
9.1 Japan Infantile Spasms Therapeutics Market Size (2015-2020)
9.2 Infantile Spasms Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Infantile Spasms Therapeutics Market Size by Type (2015-2020)
9.4 Japan Infantile Spasms Therapeutics Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Infantile Spasms Therapeutics Market Size (2015-2020)
10.2 Infantile Spasms Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Infantile Spasms Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Infantile Spasms Therapeutics Market Size by Application (2015-2020)
11 India
11.1 India Infantile Spasms Therapeutics Market Size (2015-2020)
11.2 Infantile Spasms Therapeutics Key Players in India (2019-2020)
11.3 India Infantile Spasms Therapeutics Market Size by Type (2015-2020)
11.4 India Infantile Spasms Therapeutics Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Infantile Spasms Therapeutics Market Size (2015-2020)
12.2 Infantile Spasms Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Infantile Spasms Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Infantile Spasms Therapeutics Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Mallinckrodt
13.1.1 Mallinckrodt Company Details
13.1.2 Mallinckrodt Business Overview and Its Total Revenue
13.1.3 Mallinckrodt Infantile Spasms Therapeutics Introduction
13.1.4 Mallinckrodt Revenue in Infantile Spasms Therapeutics Business (2015-2020))
13.1.5 Mallinckrodt Recent Development
13.2 H. Lundbeck
13.2.1 H. Lundbeck Company Details
13.2.2 H. Lundbeck Business Overview and Its Total Revenue
13.2.3 H. Lundbeck Infantile Spasms Therapeutics Introduction
13.2.4 H. Lundbeck Revenue in Infantile Spasms Therapeutics Business (2015-2020)
13.2.5 H. Lundbeck Recent Development
13.3 Insys Therapeutics
13.3.1 Insys Therapeutics Company Details
13.3.2 Insys Therapeutics Business Overview and Its Total Revenue
13.3.3 Insys Therapeutics Infantile Spasms Therapeutics Introduction
13.3.4 Insys Therapeutics Revenue in Infantile Spasms Therapeutics Business (2015-2020)
13.3.5 Insys Therapeutics Recent Development
13.4 Orphelia Pharma
13.4.1 Orphelia Pharma Company Details
13.4.2 Orphelia Pharma Business Overview and Its Total Revenue
13.4.3 Orphelia Pharma Infantile Spasms Therapeutics Introduction
13.4.4 Orphelia Pharma Revenue in Infantile Spasms Therapeutics Business (2015-2020)
13.4.5 Orphelia Pharma Recent Development
13.5 Valerion Therapeutics
13.5.1 Valerion Therapeutics Company Details
13.5.2 Valerion Therapeutics Business Overview and Its Total Revenue
13.5.3 Valerion Therapeutics Infantile Spasms Therapeutics Introduction
13.5.4 Valerion Therapeutics Revenue in Infantile Spasms Therapeutics Business (2015-2020)
13.5.5 Valerion Therapeutics Recent Development
13.6 Catalyst Pharmaceuticals
13.6.1 Catalyst Pharmaceuticals Company Details
13.6.2 Catalyst Pharmaceuticals Business Overview and Its Total Revenue
13.6.3 Catalyst Pharmaceuticals Infantile Spasms Therapeutics Introduction
13.6.4 Catalyst Pharmaceuticals Revenue in Infantile Spasms Therapeutics Business (2015-2020)
13.6.5 Catalyst Pharmaceuticals Recent Development
13.7 Anavex Life Sciences
13.7.1 Anavex Life Sciences Company Details
13.7.2 Anavex Life Sciences Business Overview and Its Total Revenue
13.7.3 Anavex Life Sciences Infantile Spasms Therapeutics Introduction
13.7.4 Anavex Life Sciences Revenue in Infantile Spasms Therapeutics Business (2015-2020)
13.7.5 Anavex Life Sciences Recent Development
13.8 Retrophin
13.8.1 Retrophin Company Details
13.8.2 Retrophin Business Overview and Its Total Revenue
13.8.3 Retrophin Infantile Spasms Therapeutics Introduction
13.8.4 Retrophin Revenue in Infantile Spasms Therapeutics Business (2015-2020)
13.8.5 Retrophin Recent Development
13.9 GW Pharmaceuticals
13.9.1 GW Pharmaceuticals Company Details
13.9.2 GW Pharmaceuticals Business Overview and Its Total Revenue
13.9.3 GW Pharmaceuticals Infantile Spasms Therapeutics Introduction
13.9.4 GW Pharmaceuticals Revenue in Infantile Spasms Therapeutics Business (2015-2020)
13.9.5 GW Pharmaceuticals Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Tables
Table 1. Infantile Spasms Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by Infantile Spasms Therapeutics Revenue
Table 3. Ranking of Global Top Infantile Spasms Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Infantile Spasms Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Oral
Table 6. Key Players of Injection
Table 7. COVID-19 Impact Global Market: (Four Infantile Spasms Therapeutics Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Infantile Spasms Therapeutics Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Infantile Spasms Therapeutics Players to Combat Covid-19 Impact
Table 12. Global Infantile Spasms Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Infantile Spasms Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Infantile Spasms Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Infantile Spasms Therapeutics Market Share by Regions (2015-2020)
Table 16. Global Infantile Spasms Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Infantile Spasms Therapeutics Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Infantile Spasms Therapeutics Market Growth Strategy
Table 22. Main Points Interviewed from Key Infantile Spasms Therapeutics Players
Table 23. Global Infantile Spasms Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 24. Global Infantile Spasms Therapeutics Market Share by Players (2015-2020)
Table 25. Global Top Infantile Spasms Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Infantile Spasms Therapeutics as of 2019)
Table 26. Global Infantile Spasms Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Infantile Spasms Therapeutics Product Solution and Service
Table 29. Date of Enter into Infantile Spasms Therapeutics Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Infantile Spasms Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 32. Global Infantile Spasms Therapeutics Market Size Share by Type (2015-2020)
Table 33. Global Infantile Spasms Therapeutics Revenue Market Share by Type (2021-2026)
Table 34. Global Infantile Spasms Therapeutics Market Size Share by Application (2015-2020)
Table 35. Global Infantile Spasms Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 36. Global Infantile Spasms Therapeutics Market Size Share by Application (2021-2026)
Table 37. North America Key Players Infantile Spasms Therapeutics Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Infantile Spasms Therapeutics Market Share (2019-2020)
Table 39. North America Infantile Spasms Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 40. North America Infantile Spasms Therapeutics Market Share by Type (2015-2020)
Table 41. North America Infantile Spasms Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 42. North America Infantile Spasms Therapeutics Market Share by Application (2015-2020)
Table 43. Europe Key Players Infantile Spasms Therapeutics Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Infantile Spasms Therapeutics Market Share (2019-2020)
Table 45. Europe Infantile Spasms Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Infantile Spasms Therapeutics Market Share by Type (2015-2020)
Table 47. Europe Infantile Spasms Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Infantile Spasms Therapeutics Market Share by Application (2015-2020)
Table 49. China Key Players Infantile Spasms Therapeutics Revenue (2019-2020) (Million US$)
Table 50. China Key Players Infantile Spasms Therapeutics Market Share (2019-2020)
Table 51. China Infantile Spasms Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 52. China Infantile Spasms Therapeutics Market Share by Type (2015-2020)
Table 53. China Infantile Spasms Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 54. China Infantile Spasms Therapeutics Market Share by Application (2015-2020)
Table 55. Japan Key Players Infantile Spasms Therapeutics Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Infantile Spasms Therapeutics Market Share (2019-2020)
Table 57. Japan Infantile Spasms Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Infantile Spasms Therapeutics Market Share by Type (2015-2020)
Table 59. Japan Infantile Spasms Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Infantile Spasms Therapeutics Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Infantile Spasms Therapeutics Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Infantile Spasms Therapeutics Market Share (2019-2020)
Table 63. Southeast Asia Infantile Spasms Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Infantile Spasms Therapeutics Market Share by Type (2015-2020)
Table 65. Southeast Asia Infantile Spasms Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Infantile Spasms Therapeutics Market Share by Application (2015-2020)
Table 67. India Key Players Infantile Spasms Therapeutics Revenue (2019-2020) (Million US$)
Table 68. India Key Players Infantile Spasms Therapeutics Market Share (2019-2020)
Table 69. India Infantile Spasms Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 70. India Infantile Spasms Therapeutics Market Share by Type (2015-2020)
Table 71. India Infantile Spasms Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 72. India Infantile Spasms Therapeutics Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Infantile Spasms Therapeutics Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Infantile Spasms Therapeutics Market Share (2019-2020)
Table 75. Central & South America Infantile Spasms Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Infantile Spasms Therapeutics Market Share by Type (2015-2020)
Table 77. Central & South America Infantile Spasms Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Infantile Spasms Therapeutics Market Share by Application (2015-2020)
Table 79. Mallinckrodt Company Details
Table 80. Mallinckrodt Business Overview
Table 81. Mallinckrodt Product
Table 82. Mallinckrodt Revenue in Infantile Spasms Therapeutics Business (2015-2020) (Million US$)
Table 83. Mallinckrodt Recent Development
Table 84. H. Lundbeck Company Details
Table 85. H. Lundbeck Business Overview
Table 86. H. Lundbeck Product
Table 87. H. Lundbeck Revenue in Infantile Spasms Therapeutics Business (2015-2020) (Million US$)
Table 88. H. Lundbeck Recent Development
Table 89. Insys Therapeutics Company Details
Table 90. Insys Therapeutics Business Overview
Table 91. Insys Therapeutics Product
Table 92. Insys Therapeutics Revenue in Infantile Spasms Therapeutics Business (2015-2020) (Million US$)
Table 93. Insys Therapeutics Recent Development
Table 94. Orphelia Pharma Company Details
Table 95. Orphelia Pharma Business Overview
Table 96. Orphelia Pharma Product
Table 97. Orphelia Pharma Revenue in Infantile Spasms Therapeutics Business (2015-2020) (Million US$)
Table 98. Orphelia Pharma Recent Development
Table 99. Valerion Therapeutics Company Details
Table 100. Valerion Therapeutics Business Overview
Table 101. Valerion Therapeutics Product
Table 102. Valerion Therapeutics Revenue in Infantile Spasms Therapeutics Business (2015-2020) (Million US$)
Table 103. Valerion Therapeutics Recent Development
Table 104. Catalyst Pharmaceuticals Company Details
Table 105. Catalyst Pharmaceuticals Business Overview
Table 106. Catalyst Pharmaceuticals Product
Table 107. Catalyst Pharmaceuticals Revenue in Infantile Spasms Therapeutics Business (2015-2020) (Million US$)
Table 108. Catalyst Pharmaceuticals Recent Development
Table 109. Anavex Life Sciences Company Details
Table 110. Anavex Life Sciences Business Overview
Table 111. Anavex Life Sciences Product
Table 112. Anavex Life Sciences Revenue in Infantile Spasms Therapeutics Business (2015-2020) (Million US$)
Table 113. Anavex Life Sciences Recent Development
Table 114. Retrophin Business Overview
Table 115. Retrophin Product
Table 116. Retrophin Company Details
Table 117. Retrophin Revenue in Infantile Spasms Therapeutics Business (2015-2020) (Million US$)
Table 118. Retrophin Recent Development
Table 119. GW Pharmaceuticals Company Details
Table 120. GW Pharmaceuticals Business Overview
Table 121. GW Pharmaceuticals Product
Table 122. GW Pharmaceuticals Revenue in Infantile Spasms Therapeutics Business (2015-2020) (Million US$)
Table 123. GW Pharmaceuticals Recent Development
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Infantile Spasms Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Oral Features
Figure 3. Injection Features
Figure 4. Global Infantile Spasms Therapeutics Market Share by Application: 2020 VS 2026
Figure 5. Hospital Case Studies
Figure 6. Clinic Case Studies
Figure 7. Infantile Spasms Therapeutics Report Years Considered
Figure 8. Global Infantile Spasms Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 9. Global Infantile Spasms Therapeutics Market Share by Regions: 2020 VS 2026
Figure 10. Global Infantile Spasms Therapeutics Market Share by Regions (2021-2026)
Figure 11. Porter's Five Forces Analysis
Figure 12. Global Infantile Spasms Therapeutics Market Share by Players in 2019
Figure 13. Global Top Infantile Spasms Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Infantile Spasms Therapeutics as of 2019
Figure 14. The Top 10 and 5 Players Market Share by Infantile Spasms Therapeutics Revenue in 2019
Figure 15. North America Infantile Spasms Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 16. Europe Infantile Spasms Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. China Infantile Spasms Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Japan Infantile Spasms Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Southeast Asia Infantile Spasms Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. India Infantile Spasms Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Central & South America Infantile Spasms Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Mallinckrodt Total Revenue (US$ Million): 2019 Compared with 2018
Figure 23. Mallinckrodt Revenue Growth Rate in Infantile Spasms Therapeutics Business (2015-2020)
Figure 24. H. Lundbeck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. H. Lundbeck Revenue Growth Rate in Infantile Spasms Therapeutics Business (2015-2020)
Figure 26. Insys Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Insys Therapeutics Revenue Growth Rate in Infantile Spasms Therapeutics Business (2015-2020)
Figure 28. Orphelia Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Orphelia Pharma Revenue Growth Rate in Infantile Spasms Therapeutics Business (2015-2020)
Figure 30. Valerion Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Valerion Therapeutics Revenue Growth Rate in Infantile Spasms Therapeutics Business (2015-2020)
Figure 32. Catalyst Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Catalyst Pharmaceuticals Revenue Growth Rate in Infantile Spasms Therapeutics Business (2015-2020)
Figure 34. Anavex Life Sciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Anavex Life Sciences Revenue Growth Rate in Infantile Spasms Therapeutics Business (2015-2020)
Figure 36. Retrophin Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Retrophin Revenue Growth Rate in Infantile Spasms Therapeutics Business (2015-2020)
Figure 38. GW Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. GW Pharmaceuticals Revenue Growth Rate in Infantile Spasms Therapeutics Business (2015-2020)
Figure 40. Bottom-up and Top-down Approaches for This Report
Figure 41. Data Triangulation
Figure 42. Key Executives Interviewed
  • Global Thyroid Gland Disorders Treatment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 80
    Thyroid Gland Disorder Treatment is a kind of treatment method, which aims to The thyroid disorder patients, such as hypothyroidism patients and hyperthyroidism patients. When The thyroid gland does not produce sufficient hypothyroidism or too much hyperthyroidism, The body metabolism and functioning will be disrupted. The global Thyroid Gland Disorders Treatment market was valued at US$ 2950 million in 2023 and is anticipated to reach US$ 3871.9 million by 2030, witnessing a CAGR o......
  • Global Brachytherapy Afterloaders, Brachytherapy Seeds Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 98
    According to our LPI (LP Information) latest study, the global Brachytherapy Afterloaders, Brachytherapy Seeds market size was valued at US$ 150.8 million in 2023. With growing demand in downstream market, the Brachytherapy Afterloaders, Brachytherapy Seeds is forecast to a readjusted size of US$ 168.1 million by 2030 with a CAGR of 1.6% during review period. The research report highlights the growth potential of the global Brachytherapy Afterloaders, Brachytherapy Seeds market. Brachyth......
  • Global Peptide Therapeutics Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 109
    According to our LPI (LP Information) latest study, the global Peptide Therapeutics market size was valued at US$ 33800 million in 2023. With growing demand in downstream market, the Peptide Therapeutics is forecast to a readjusted size of US$ 63130 million by 2030 with a CAGR of 9.3% during review period. The research report highlights the growth potential of the global Peptide Therapeutics market. Peptide Therapeutics are expected to show stable growth in the future market. However, pr......
  • Global Microbiome Therapeutics Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 155
    According to our LPI (LP Information) latest study, the global Microbiome Therapeutics market size was valued at US$ 89 million in 2023. With growing demand in downstream market, the Microbiome Therapeutics is forecast to a readjusted size of US$ 916.3 million by 2030 with a CAGR of 39.5% during review period. The research report highlights the growth potential of the global Microbiome Therapeutics market. Microbiome Therapeutics are expected to show stable growth in the future market. H......
  • Global Anti-inflammatory Therapeutics Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 109
    According to our LPI (LP Information) latest study, the global Anti-inflammatory Therapeutics market size was valued at US$ 108140 million in 2023. With growing demand in downstream market, the Anti-inflammatory Therapeutics is forecast to a readjusted size of US$ 166150 million by 2030 with a CAGR of 6.3% during review period. The research report highlights the growth potential of the global Anti-inflammatory Therapeutics market. Anti-inflammatory Therapeutics are expected to show stabl......
  • Global Enzyme Replacement Therapy Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 113
    According to our LPI (LP Information) latest study, the global Enzyme Replacement Therapy market size was valued at US$ 11570 million in 2023. With growing demand in downstream market, the Enzyme Replacement Therapy is forecast to a readjusted size of US$ 29900 million by 2030 with a CAGR of 14.5% during review period. The research report highlights the growth potential of the global Enzyme Replacement Therapy market. Enzyme Replacement Therapy are expected to show stable growth in the f......
  • Global Infantile Spasms Therapeutics Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 84
    According to our LPI (LP Information) latest study, the global Infantile Spasms Therapeutics market size was valued at US$ 138.9 million in 2023. With growing demand in downstream market, the Infantile Spasms Therapeutics is forecast to a readjusted size of US$ 179.6 million by 2030 with a CAGR of 3.7% during review period. The research report highlights the growth potential of the global Infantile Spasms Therapeutics market. Infantile Spasms Therapeutics are expected to show stable grow......
  • Global Hormone Replacement Therapy Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 128
    According to our LPI (LP Information) latest study, the global Hormone Replacement Therapy market size was valued at US$ 16090 million in 2023. With growing demand in downstream market, the Hormone Replacement Therapy is forecast to a readjusted size of US$ 17930 million by 2030 with a CAGR of 1.6% during review period. The research report highlights the growth potential of the global Hormone Replacement Therapy market. Hormone Replacement Therapy are expected to show stable growth in th......
  • Global Plasma Therapy Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 107
    According to our LPI (LP Information) latest study, the global Plasma Therapy market size was valued at US$ 265.3 million in 2023. With growing demand in downstream market, the Plasma Therapy is forecast to a readjusted size of US$ 529.4 million by 2030 with a CAGR of 10.4% during review period. The research report highlights the growth potential of the global Plasma Therapy market. Plasma Therapy are expected to show stable growth in the future market. However, product differentiation, ......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs